Stockholders' Equity - Narrative (Details)				12 Months Ended			15 Months Ended	31 Months Ended	120 Months Ended
	Jun. 05, 2025 shares	Jun. 03, 2024 shares	Jun. 30, 2015 shares	Dec. 31, 2025 USD ($) vote $ / shares shares	Dec. 31, 2024 USD ($) $ / shares shares	Dec. 31, 2023 USD ($) $ / shares	Dec. 31, 2023 USD ($) shares	Dec. 31, 2025 USD ($) $ / shares shares	Dec. 31, 2025 USD ($) $ / shares shares	Oct. 31, 2025 USD ($)	Feb. 28, 2025 USD ($)	Jun. 05, 2023 shares	Oct. 31, 2022 USD ($)	Nov. 14, 2013 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares authorized (in shares)				200,000,000	200,000,000			200,000,000	200,000,000
Common stock, par value (in usd per share) | $ / shares				$ 0.001	$ 0.001			$ 0.001	$ 0.001
Number of voting rights | vote				1
Exercises in period, intrinsic value | $				$ 162,000	$ 22,174,000	$ 2,469,000
Unrecognized compensation cost | $				0				$ 0	$ 0
Amount of common stock repurchased under share repurchase program | $				$ 115,000,000		$ 43,522,000
October 2022 Share Repurchase Program
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share repurchase program, authorized amount | $													$ 100,000,000
Repurchase of common stock (in shares)							4,415,093
Amount of common stock repurchased under share repurchase program | $							$ 99,967,000
February 2025 Share Repurchase Program
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share repurchase program, authorized amount | $											$ 100,000,000
Stock repurchased and retired (in shares)				2,480,341
Stock repurchased and retired | $				$ 100,000,000
October 2025 Share Repurchase Program
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share repurchase program, authorized amount | $										$ 150,000,000
Stock repurchased and retired (in shares)				448,439
Stock repurchased and retired | $				$ 15,000,000
Share repurchase, remaining authorized amount | $				$ 135,000,000				135,000,000	135,000,000
Restricted Stock Units and Performance Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted, weighted average grant date fair value (in dollars per share) | $ / shares				$ 45.64	$ 43.38	$ 28.74
Fair value of shares vested | $				$ 114,186,000	$ 162,694,000	$ 85,475,000
Compensation cost not yet recognized | $				$ 231,295,000	$ 181,874,000			$ 231,295,000	$ 231,295,000
Compensation cost not yet recognized, period for recognition				2 years 25 days	2 years 29 days
The 2013 Omnibus Equity Award Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, capital shares reserved for future issuance (in shares)														5,713,899
Capital shares reserved for future issuance, annual increase, maximum (in shares)				27,579,672				27,579,672	27,579,672
Vesting period (in years)				4 years
Granted (in shares)				0				0
Shares available for grant (in shares)				0				0	0
Polyrize Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)				0
Shares available for grant (in shares)				0				0	0
The 2023 Stock Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, capital shares reserved for future issuance (in shares)												5,500,000
Granted (in shares)				0
Number of additional shares authorized (in shares)	1,880,000
2023 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of additional shares authorized (in shares)		6,280,000
2015 ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of additional shares authorized (in shares)									4,321,921
Number of shares authorized (in shares)			1,500,000
Maximum employee subscription rate			15.00%
Purchase price of common stock, percent			85.00%
2025 ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized (in shares)	8,000,000